| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 939 |
| 1 | TREPROSTINIL | 484 |
| 2 | SOMATROPIN | 354 |
| 3 | RISANKIZUMAB-RZAA | 234 |
| 4 | ORAL SEMAGLUTIDE | 222 |
| 5 | DUPILUMAB | 206 |
| 6 | TADALAFIL | 174 |
| 7 | AMBRISENTAN | 164 |
| 8 | VEDOLIZUMAB | 154 |
| 9 | LENACAPAVIR SODIUM | 149 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 486 |
| 1 | GLP-1 Receptor Agonist [EPC] | 301 |
| 2 | Interleukin-23 Antagonist [EPC] | 267 |
| 3 | Endothelin Receptor Antagonist [EPC] | 250 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 229 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 224 |
| 6 | Recombinant Human Growth Hormone [EPC] | 222 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 208 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 206 |
| 9 | Corticosteroid [EPC] | 170 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 117 | 0.1307 |
| 1 | Recombinant Human Growth Hormone [EPC] | 222 | 0.0101 |
| 2 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 3 | Endoglycosidase [EPC] | 11 | 0.0059 |
| 4 | Interferon alfa-2b [EPC] | 11 | 0.0059 |
| 5 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 6 | Human Immunoglobulin G [EPC] | 101 | 0.0048 |
| 7 | Provitamin D2 Compound [EPC] | 120 | 0.0040 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 9 | Prostacycline Vasodilator [EPC] | 486 | 0.0035 |